Can Electroporation Revive Gene Therapy?
Executive Summary
As regulators increase their scrutiny of viral vectors for gene therapy and set the bars for safety ever higher, some industry observers have begun questioning whether gene therapy will ever become a commercial reality. The difficulties in the field may turn out to be a life-saver for MaxCyte Inc. Its managers think their flow electroporation technology could be a platform for transforming patients' cells and getting them to produce a desired protein--without viruses, and the risks they bring.You may also be interested in...
Vical Leaves Gene Therapy for Vaccines
TheraMed Inc.
Health And Wellness Product Trademark Review 10 December, 2019
Need a specific report? 1000+ reports available
Buy Reports